Abstract
Increasing bacterial resistance to available antibiotics makes the discovery of novel efficacious antibacterial agents a priority. A previous report showed that listeriolysin O (LLO) is a critical virulence factor and suggested that it is a target for developing anti-virulence drugs against Listeria monocytogenes infections. In this study, we report the discovery of LLO natural compound inhibitors with differential activity by using hemolysis assay. The mechanism of action of the inhibitors was consistent with that of fisetin, a natural flavonoid without antimicrobial activity, which we showed in our previous report via molecular simulation. Furthermore, a substantial increase in anti-hemolytic activity was observed when the single bond (C1-C2) was replaced by a double bond (C1-C2) in the inhibitor molecule. This change was based on the decomposition of the ligand-residue interaction, which indicated that the double bond (C1-C2) in the inhibitors was required for their inhibition of LLO. The current MD simulation work provides insights into the mechanism by which the compounds inhibit LLO at the atomic level and will be useful for the development of new, selective LLO inhibitors.
References
Nov 1, 1989·Infection and Immunity·P CossartP Berche
Apr 1, 1988·The Journal of Experimental Medicine·D A PortnoyD J Hinrichs
Apr 1, 1986·Infection and Immunity·J L GaillardP Sansonetti
Aug 1, 1996·Journal of Computer-aided Molecular Design·G M MorrisA J Olson
May 24, 2001·Immunity·B T Edelson, E R Unanue
Jul 4, 2001·Clinical Microbiology Reviews·J A Vázquez-BolandJ Kreft
Mar 20, 2002·The Journal of Cell Biology·Shaynoor Dramsi, Pascale Cossart
Aug 7, 2002·The Journal of Cell Biology·Daniel A PortnoyIan J Glomski
Oct 24, 2002·Journal of Computational Chemistry·Araz JakalianChristopher I Bayly
Feb 7, 2006·Journal of Molecular Graphics & Modelling·Junmei WangDavid A Case
Jun 16, 2006·FEMS Microbiology Reviews·Samer Kayal, Alain Charbit
Mar 3, 2009·Bioorganic & Medicinal Chemistry·Rongjing HuRuisheng Zhang
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Oct 5, 2010·European Journal of Medicinal Chemistry·Auradee PunkvangPornpan Pungpo
Nov 10, 2010·Biochemistry·Claudia Schaffner-BarberoJose M Andreu
Nov 25, 2011·Proceedings of the National Academy of Sciences of the United States of America·Pascale Cossart
May 4, 2012·The Journal of Infectious Diseases·Jiazhang QiuXuming Deng
Jun 2, 2012·Trends in Microbiology·Mélanie Anne HamonPascale Cossart
Jan 26, 2013·PLoS Computational Biology·Jing DongXuming Deng
Apr 23, 2014·Nature Communications·Stefan KösterÖzkan Yildiz
May 7, 2014·Sub-cellular Biochemistry·Stephanie Seveau
Sep 19, 2014·The Journal of Infectious Diseases·Jianfeng WangXuming Deng
Citations
Jul 21, 2016·Chemical Reviews·Laura Nunes SilvaDanielle Silva Trentin
Feb 6, 2017·Nature Communications·Robert ThänertEva Medina
Apr 15, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bingrun LiuDacheng Wang
Mar 8, 2018·Journal of Molecular Modeling·Lili DongJianjun Zhang
Oct 20, 2018·Journal of Cellular and Molecular Medicine·Jianfeng WangXuming Deng
Jul 25, 2018·The EMBO Journal·Hang YangHongping Wei
Mar 2, 2018·Frontiers in Microbiology·Jianfeng WangXuming Deng
Jun 2, 2017·Frontiers in Immunology·Xuan ZhouXuming Deng
Oct 13, 2018·Applied Microbiology and Biotechnology·Guizhen WangXiaodi Niu
May 14, 2020·BMC Microbiology·Gen LiZhongmei Wen
Feb 6, 2017·Frontiers in Cellular and Infection Microbiology·Jianfeng WangXuming Deng
Oct 31, 2020·Frontiers in Pharmacology·Yanan YangXiaodi Niu
Aug 24, 2019·Microbiology Spectrum·Jörgen Johansson, Nancy E Freitag
Jun 3, 2021·Pharmaceutics·Giuliana DonadioFabrizio Dal Piaz
Apr 10, 2018·ACS Chemical Neuroscience·N Arul MuruganHans Ågren